Institut Fuer Frauengesundheit
Clinical trials sponsored by Institut Fuer Frauengesundheit, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Breast cancer drug adherence under the microscope: will patients stick with treatment? Results expected Sep 2026 (estimated)
-
Coaching may boost adherence to breast cancer therapy
Disease control Recruiting nowThis study tests whether personalized coaching based on patient typology helps women with HR+/HER2- early breast cancer stick with their ribociclib treatment longer. About 548 participants will either receive standard education or tailored coaching using a validated tool. The goa…
Sponsor: Institut fuer Frauengesundheit • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Breast cancer drug adherence under the microscope: will patients stick with treatment?
Knowledge-focused Recruiting nowThis observational study tracks 200 women with high-risk HR+/HER2- early breast cancer to see how many continue taking abemaciclib six months after starting. Researchers will review therapy data from 2023 to 2025. The goal is to understand real-world persistence, not to test a ne…
Sponsor: Institut fuer Frauengesundheit • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC